Earnings Release • Aug 21, 2019
Earnings Release
Open in ViewerOpens in native device viewer

OVERVIEW OF SECOND QUARTER 2019 CONSOLIDATED RESULTS FOR CARASENT ASA (IN NOK AND IFRS).

Revenues of NOK 11,2 million as compared to no NOK 5,8 millon during Q2 -18.

Net income of NOK 0,3 million as compared to net loss of NOK 3,0 million during Q2 -18.

Cash balances of NOK 7,2 million at June 30, 2019.

Revenues

Customers


EBITDA
Market development and accelerated strategic expansion


The proportion of the population aged 60 or older
Medical progress and the ability to manage illness are contributing to an overall increased average lifetime
Chronic diseases, such as diabetes, obesity and certain cardiovascular diseases, are increasing and are treated over longer periods of time

The need for high-quality healthcare at lower cost to society has therefore never been greater.

Digitalization is transforming healthcare
The use of digital solutions is increasing availability to patients
Digital solutions also increase opportunities to share necessary and relevant information
Receive healthcare on a remote basis when doctors are available via chat or video,
Continue to invest in Evimeria EMR AB and Webdoc and expand in nearby and similar segments

Actively searching to expand geographical and/or service offering through partnerships or acquisitions within the health tech segment

Focus in Scandinavia (Nordics)
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.